Similar articles

• The evidence shows that allogeneic transfusion is associated with reduced survival after coronary artery bypass surgery.

  Gross I, Shander A, Waters JH. Gross I, et al. Anesthesiology. 2010 Mar;112(3):760-1; author reply 762-3. doi: 10.1097/ALN.0b013e3181cd7ab9. Anesthesiology. 2010. PMID: 20179522 No abstract available.
• Does blood transfusion affect intermediate survival after coronary artery bypass surgery?

  Mikkola R, Heikkinen J, Lahtinen J, Paone R, Juvonen T, Biancari F. Mikkola R, et al. Scand J Surg. 2013;102(2):110-6. doi: 10.1177/1457496913482246. Scand J Surg. 2013. PMID: 23820687
• Invited commentary.

  Koch CG. Koch CG. Ann Thorac Surg. 2008 Feb;85(2):487. doi: 10.1016/j.athoracsur.2007.10.067. Ann Thorac Surg. 2008. PMID: 18222249 No abstract available.
• Clinical and molecular basis of transfusion-induced immunomodulation: summary of the proceedings of a state-of-the-art conference.

  Blajchman MA, Dzik S, Vamvakas EC, Sweeney J, Snyder EL. Blajchman MA, et al. Transfus Med Rev. 2001 Apr;15(2):108-35. doi: 10.1053/tmrv.2001.22614. Transfus Med Rev. 2001. PMID: 11309732 Review. No abstract available.
• A review of transfusion risks and optimal management of perioperative bleeding with cardiac surgery.

  Despotis G, Eby C, Lublin DM. Despotis G, et al. Transfusion. 2008 Mar;48(1 Suppl):2S-30S. doi: 10.1111/j.1537-2995.2007.01573.x. Transfusion. 2008. PMID: 18302579 Review. No abstract available.